The molecule target turns towards and treats into a anticancer

The molecule target turns towards and treats into a anticancer focus
It is reported (reporter Chen Qing) The reporter closed in Shanghai since the day before yesterday " The Sino-German lung cancer forums on the third " On learn,is it biological target, to treating with individualing and becoming by focuses against cancer already. This forum executive chairman, Shanghai lung subject hospital tumour head of the department Professor Zhou CaiCun introduce, with the intersection of molecule and to treat for biological treatment of representative, open up new route for treatment of lung cancer target, and make the enormous achievement on clinic.

The American scholar found 7 years ago it was good that EGFR gene mutation patient used the target to treat curative effect to the treatment medicine EGFR-TKIs for the first time. But, to which particular lung cancer colonies on earth does this kind of target have better curative effect to the treatment medicine, to what colony's curative effect of lung cancer is relatively bad? Head the list of signers by Zhou CaiCun Professor item 1 compare target with treat to study OPTIMAL lung cancer of EGFR sudden change patient to the intersection of medicine and the intersection of form and medicine and chemotherapy in the world, verify, accept target efficient to up to 83% to treatment, person have progress survive 13.7 months such as Damien in the patient finally; Efficient chemotherapy 36% only, location have progress that survive for 4.6 months in the patient. The relevant research results are published on the international authoritative tumour magazine " lancet tumour " published last month.


The molecule target turns towards and treats into a anticancer focus